XTX Topco’s Profound Medical PROF Stock Holding History

XTX Topco’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,132	Closed	-$114K	–	2955
2024 Q4	$114K	Buy	+15,132	New	+$116K	0.01%	1742

Other funds holding PROF

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

TIM

Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

XTX Topco's PROF Position: Q1 2025 in Review

XTX Topco sold out of Profound Medical (PROF) in Q1 2025, closing a stake of 15,132 shares — an estimated $114K sold.

XTX Topco first reported a position in PROF in Q4 2024 and held it in 1 quarter. The position peaked at $114K in Q4 2024. 49 funds tracked by Wall St. Rank hold PROF as of Q1 2025.

XTX Topco reported no remaining Profound Medical position as of Q1 2025 after selling out during the quarter.
XTX Topco sold 15,132 Profound Medical shares in Q1 2025, an estimated $114K.
XTX Topco first reported a position in Profound Medical in Q4 2024 and held it in 1 quarter.
XTX Topco's Profound Medical position peaked at $114K in Q4 2024.
49 funds tracked by Wall St. Rank held Profound Medical as of Q1 2025.

Based on XTX Topco's 13F filing for Q1 2025, filed 8 May 2025.